Publications
254
Citations
6,908
Est. group size
~21
Recurring co-author estimate
Active years
31
Publishing since 1996
Typically publishes in teams of ~15 · 21% small-team papers (≤3 authors) · across 9 venues
- Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC
JTO Clinical and Research Reports · 2024
- Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy
The Oncologist · 2023
- Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer
Cancer Investigation · 2023
- P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer
Journal of Thoracic Oncology · 2023
- Preoperative dose-dense docetaxel and cyclophosphamide alternating with epirubicin and cisplatin(ddDCEP): an effective, novel way of incorporating platinum in the treatment of early TNBC
Research Square · 2023
- Supplementary Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
2023
- Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
2023
- Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
2023
- Supplementary Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
2023
- Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an alternative platinum-containing regimen in 116 patients with early triple negative breast cancer
Research Square · 2023
- Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer
UNC Libraries · 2020
- Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?
Translational Lung Cancer Research · 2018
- The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine
Biomarkers in Cancer · 2016
- Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors
Lung Cancer · 2016
- International Journal of Radiation Oncology*Biology*Physics×12
- Journal of Clinical Oncology×7
- Journal of Thoracic Oncology×5
- Cancers×4
- Research Square×4
- Naoki Furuya
Medicine · The Ohio State University
- Po‐Lan Su
Medicine · The Ohio State University
- David P. Carbone
Medicine · The Ohio State University
- Angel Qin
Medicine · University of Michigan
- Hossein Borghaei
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile